Blog
Are Basic Materials Stocks Lagging Lynas Rare Earths Limited - Sponsored ADR (LYSDY) This Year?
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Lynas Rare Earths Limited - Sponsored ADR (LYSDY) is a
Should Value Investors Buy Aegon (AEG) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Here's Why Barrick Mining (B) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Is Smithfield Foods, Inc. (SFD) Outperforming Other Consumer Staples Stocks This Year?
For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Smithfield Foods, Inc. (SFD) been one of those
Is Banco Do Brasil (BDORY) Stock Undervalued Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
TG Therapeutics TGTX announced that it has completed enrollment in the phase III study evaluating the subcutaneous formulation of its sole marketed drug, Briumvi (ublituximab-xiiy), for treating
Cracker Barrel Old Country Store (CBRL) Just Flashed Golden Cross Signal: Do You Buy?
After reaching an important support level, Cracker Barrel Old Country Store (CBRL) could be a good stock pick from a technical perspective. CBRL surpassed resistance at the 20-day moving average
NTLA Stock Rises 20% in 3 Months: Here's What You Should Know
Shares of Intellia Therapeutics NTLA have risen 19.6% in the past three months after it outlined key pipeline goals for 2026. The encouraging clinical progress with its pipeline candidates likely
LLY Stock Down as FDA Asks for More Safety Data on Oral Obesity Pill
Eli Lilly and Company’s LLY stock was down around 1.9% on Wednesday in response to a letter from the FDA that instructed the company to “provide additional safety data” on its newly approved oral
4 Stocks Trading Near 52-Week Highs With Room to Rise Further
Stocks hitting their 52-week high and delivering consistent performances offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived
U.S. Bancorp (USB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
U.S. Bancorp (USB) reported $7.29 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 4.7%. EPS of $1.18 for the same period compares to $1.03 a year ago.
Travelers (TRV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Travelers (TRV) reported $11.88 billion in revenue for the quarter ended March 2026, representing no change year over year. EPS of $7.71 for the same period compares to $1.91 a year ago.
The
Wall Street Bulls Look Optimistic About AppFolio (APPF): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Prologis (PLD) Reports Q1 Earnings: What Key Metrics Have to Say
Prologis (PLD) reported $2.13 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 6.9%. EPS of $1.50 for the same period compares to $0.63 a year ago.
The
Compared to Estimates, KeyCorp (KEY) Q1 Earnings: A Look at Key Metrics
For the quarter ended March 2026, KeyCorp (KEY) reported revenue of $1.95 billion, up 10.3% over the same period last year. EPS came in at $0.44, compared to $0.33 in the year-ago quarter.
The
Is It Worth Investing in Archer Aviation (ACHR) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Compared to Estimates, Citizens Financial Group (CFG) Q1 Earnings: A Look at Key Metrics
Citizens Financial Group (CFG) reported $2.17 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 12%. EPS of $1.13 for the same period compares to $0.77 a
Brokers Suggest Investing in Cava (CAVA): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Manpower (MAN) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended March 2026, ManpowerGroup (MAN) reported revenue of $4.51 billion, up 10.3% over the same period last year. EPS came in at $0.51, compared to $0.44 in the year-ago quarter.
The
PepsiCo (PEP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
PepsiCo (PEP) reported $19.44 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 8.5%. EPS of $1.61 for the same period compares to $1.48 a year ago.
The
Wall Street Bulls Look Optimistic About Snowflake (SNOW): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
MPLX LP (MPLX) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
The Bank of New York Mellon (BK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The Bank of New York Mellon Corporation (BK) reported $5.41 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 12.9%. EPS of $2.25 for the same period




